Autism
Research On NeurOptimal® For Autism
Autism, better known as autism spectrum disorder (ASD), is a complex developmental condition involving persistent challenges in social interaction, restricted or repetitive behaviours, speech and nonverbal communication. The National Autism Spectrum Disorder Surveillance System (NASS) reports that, in Canada, 1 in 66 children and youth between the ages of 5 and 17 has ASD.
The effects of ASD and the severity of symptoms are different in each person. Many subtypes exist that are influenced by a combination of genetic and environmental factors, but they are often accompanied by sensory sensitivities, gastrointestinal disorders, seizures or sleep disorders. People with autism may also have mental health challenges such as anxiety and depression. However, each person with autism has their own set of strengths and challenges.
Neurofeedback and Emotional Regulation
NeurOptimal® is not a treatment for autism, but some research has explored its potential to support emotional regulation in individuals with ASD.
One pilot study titled “Improving Emotional Regulation Using NeurOptimal® Training for ASD Youth” reported observations suggesting a reduction in challenges related to emotional regulation following neurofeedback sessions. While the initial findings are encouraging, researchers note the need for larger-scale studies with more controlled variables to confirm and expand upon these results.